The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations
Christophe Soussan, Anette Kjellgren
International Journal of Drug Policy March 23, 2016 DOI: 10.1016/j.drugpo.2016.03.007 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional online survey Peer reviewed |
|---|---|
| Sample size | 619 |
| Population | International users of novel psychoactive substances recruited via bluelight.org |
| Measures | WHO-5 Wellbeing Index |
| Topics | Addiction |
| Keywords | Pleasure Harm reduction Incentive Sample material Public health Psychotherapist |
| Citations | 152 |
| Key findings | Pleasure and enjoyment were the main incentives for NPS use overall. Hallucinogen use was motivated by self-exploration and spiritual attainment with low addiction potential, whereas opioid and GABA-acting substance use was motivated by coping with higher addiction potential. Synthetic cannabinoids were least appreciated and used mainly due to availability and legality. |
Abstract
Background: The increasing number of Novel Psychoactive Substances (NPS) constitutes a challenge for public health agencies and researchers worldwide. Scientific studies about NPS and their users are limited and there is a need to explore the general motivations for NPS use but also to examine if and how the motivations differ between substances from separate effect classes. The aim of the present study was to investigate the characteristics, including attitudes and motivations, of a self-selected sample of international NPS users.
Methods: An online survey containing questions about drug use history, attitudes, motivations for use, and WHO-5 Wellbeing Index was promoted at the drug discussion forum bluelight.org. The data was analysed using SPSS.
Results: The sample consisted of 619 international NPS users with overall good emotional well-being despite extensive experience of both traditional and novel drugs. The main incentive for use of NPS in general was pleasure and enjoyment. However, going beyond the general approach to NPS revealed significant variations between drug groups. For example, the use of hallucinogens was substantially motivated by self-exploration and spiritual attainment and showed very low levels of addiction potential while the use of opioids and especially GABA activating substances was mainly motivated by coping and showed much higher levels of addiction potential. Synthetic cannabinoids were the least appreciated and least likely to be used again, and were mainly motivated by circumstances such as availability and legality.
Conclusion: Understanding the different motivations for NPS use in terms of drug groups could enable more effective prevention and consequently a reduction in harm.
Comparable studies
Other cross-sectional and survey studies on addiction, most cited first.
Citations in the library
Cited by 21
- Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure British Journal of Pharmacology April 20, 2017
- Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches Harm Reduction Journal September 4, 2017
- Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users Contemporary Drug Problems September 1, 2019
- Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review September 1, 2022
- Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). Neurotoxicology May 1, 2018
and 16 more in the library
Cites 3
- Heaven and Hell—A Phenomenological Study of Recreational Use of 4-HO-MET in Sweden Journal of Psychoactive Drugs July 1, 2011
- Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review March 1, 2016
- Harm reduction and knowledge exchange-a qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal September 8, 2014